More Polio Vaccine Violence

Just three days after five people involved in the polio vaccine effort in Pakistan were shot by unidentified assailants, three more are killed.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A child receives an oral polio vaccine in IndiaWIKIMEDIAThree polio vaccinators in Pakistan were shot and killed yesterday (December 19), bringing this week’s death toll to nine, with two additional people injured in the attacks. The Taliban is not the confirmed source of the attacks, but is highly suspected. The group has opposed polio vaccination, for fear that it’s a cover for a more sinister plot, such as sending in American spies spies or sterilizing Muslim children.

For now, the Pakistani government has suspended the vaccination campaign, Oliver Rosenbauer, a spokesman for the World Health Organization (WHO), told ScienceInsider, which could affect future efforts; such organized drives are usually held four to six times per year. “For sure this is a major setback,” Rosenbauer said.

Globally, since polio vaccinations efforts were first launched in 1988, polio cases worldwide have dropped more than 99 percent. Pakistan, Nigeria, and Afghanistan are the three countries where polio is known to still be endemic.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo